EUVIMEDEUVIMED entdecken
Crossref

Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen

Li Lin-Hui iD, Zha Yuan-Yuan, Liu Ming-Yu, Hong Xu-Dong, Ding Yin-Jia, Zhou Yue, Fei Yang-Hong-Hong iD, Chen Ai-Fen, Zhang Xu-Dong, Chen Zheng-Li, Jin Jian iD

Journal of Burn Care & Research · 06.09.2024 · 45 (5) · 1269-1273

DOI: 10.1093/jbcr/irae040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Burn Care & Research, online erschienen am 13.03.2024. Verfasst von Li Lin-Hui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic, Collagen Type III, Collagen Type I, Recombinant Proteins. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Science and Technology Action Innovation Plan of Shanghai, Young Innovative Talents Project of Zhejiang Health Science and Technology Plan, Medical and Health Science and Technology Project of Hangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic scar development is a complication associated with wound healing, impacting local appearance and function. The type I/III collagen ratio affects the extent of hypertrophic scarring; a reduced ratio can ameliorate this. In this study, recombinant human collagen type III was developed. Liquid chromatography–tandem mass spectrometry was used to determine its amino acid sequence and confirm its high level of homology with natural human type III collagen. Recombinant human collagen type III displayed no cytotoxicity and did not confer skin irritation and sensitization. Immunofluorescence and western blot analyses of histidine following incubation with fibroblasts suggested cell entry of recombinant human collagen type III. Furthermore, recombinant human collagen type III promoted the synthesis of the natural type III collagen in fibroblasts, resulting in a more obvious increase of type III collagen content in fibroblasts than that of type I collagen, and then decreased the ratio of type I/III collagen. The results of 5-ethynyl-2ʹ-deoxyuridine staining assay suggested enhanced fibroblast proliferation. Following local injection of recombinant human collagen type III, rabbit ear scarring was significantly reduced after 60 days. Vancouver Scar Scale evaluation showed that all index scores were significantly reduced. Western blotting and Picro-Sirius red staining showed that the natural type III collagen increase in scar tissue was greater than that of type I collagen, decreasing the type I/III ratio. In summary, recombinant human collagen type III can be taken up by fibroblasts and promote natural collagen synthesis—especially that of type III—thereby reducing the type I/III ratio and improving hypertrophic scarring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cicatrix, HypertrophicCollagen Type IIICollagen Type IRecombinant ProteinsHumansAnimalsRabbitsFibroblastsWound HealingBlotting, Western

Stichwörter der Autor:innen

recombinant human collagen type IIIscarthe ratio of type I/III collagentype III collagen

Substanzen

Collagen Type IIICollagen Type IRecombinant Proteins

Autor:innen und Institutionen

  • Department of Burns, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
  • Departmement of Cadres, 967th Hospital of the Joint Logistics Support Force of PLA, Dalian 116000, China.
  • Department of Burns and Plastic, 903rd Hospital of PLA, Hangzhou 313000, China.
  • State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai 200438, China.

ORCID-Profile: Li Lin-Hui, Fei Yang-Hong-Hong, Jin Jian

Förderung

  • Science and Technology Action Innovation Plan of Shanghai
  • Young Innovative Talents Project of Zhejiang Health Science and Technology Plan
  • Medical and Health Science and Technology Project of Hangzhou
  • Special Policy for Shanghai University Science and Technology Park-Science and Technology Innovation Special Fund
  • Special Fund for Promoting High Quality Development in Shanghai-Key Fields of Industrial Strategy Technology Research-Biomedical Special Topic
  • Hangzhou Science and Technology Development Plan
  • Military Medical Science and Technology Youth Cultivation Program
  • Special Policy for Shanghai University Science and Technology Park—Science and Technology Innovation Special Fund

Zitieren

APA

Lin-Hui, L., Yuan-Yuan, Z., Ming-Yu, L., Xu-Dong, H., Yin-Jia, D., Yue, Z., Yang-Hong-Hong, F., Ai-Fen, C., Xu-Dong, Z., Zheng-Li, C., & Jian, J. (2024). Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen. Journal of Burn Care & Research, 45(5), 1269-1273. https://doi.org/10.1093/jbcr/irae040

Vancouver

Lin-Hui L, Yuan-Yuan Z, Ming-Yu L, Xu-Dong H, Yin-Jia D, Yue Z, et al. Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen. Journal of Burn Care & Research. 2024;45(5):1269-1273. doi:10.1093/jbcr/irae040

BibTeX
@article{LinHui2024,
  author = {Lin-Hui, Li and Yuan-Yuan, Zha and Ming-Yu, Liu and Xu-Dong, Hong and Yin-Jia, Ding and Yue, Zhou and Yang-Hong-Hong, Fei and Ai-Fen, Chen and Xu-Dong, Zhang and Zheng-Li, Chen and Jian, Jin},
  title = {Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen},
  journal = {Journal of Burn Care & Research},
  year = {2024},
  volume = {45},
  number = {5},
  pages = {1269--1273},
  doi = {10.1093/jbcr/irae040}
}
Kostenlos starten →